Showing results (171-180 of 5,042) with videos related to

Sort By:
Pageof 505
Multiple Sclerosis and Related Disorders|August 27, 2025
Fifteen-year longitudinal population-based study of very late-diagnosed multiple sclerosis: Epidemiological and clinical insightsClaudio Solaro, Novella Pretti, Michele Messmer Uccelli
Multiple Sclerosis and Related Disorders|July 27, 2016
Erythroblastaemia in natalizumab-treated patients with multiple sclerosisSara La Gioia, Michela Seghezzi, Valeria Barcella, et al.
Multiple Sclerosis and Related Disorders|April 8, 2020
Liver injury after methylprednisolone pulse therapy in multiple sclerosis is usually due to idiosyncratic drug-induced toxicity rather than autoimmune hepatitisHiroko Kimura, Akitoshi Takeda, Takayuki Kikukawa, et al.
Multiple Sclerosis and Related Disorders|June 21, 2020
Incidence, prevalence and characteristics of MS in São Miguel, an island in the AtlanticPedro Lopes, Ana Martins, José Lopes
Multiple Sclerosis and Related Disorders|June 20, 2020
The effectiveness of emotional wellness programs on mental health outcomes for adults with multiple sclerosis: a systematic review and meta-analysisR D Russell, L J Black, N M Pham, et al.
Multiple Sclerosis and Related Disorders|August 29, 2021
Patient experience and self-perceived biopsychosocial burden of people living with multiple sclerosis: An epidemiological survey (BPS-MuScle study) in SpainEster Moral-Torres, Óscar Fernández-Fernández, Fernando Caballero-Martínez, et al.
Multiple Sclerosis and Related Disorders|August 30, 2021
In vivo evidence of functional disconnection between brainstem monoaminergic nuclei and brain networks in multiple sclerosisTiziana Carandini, Matteo Mancini, Iulia Bogdan, et al.
Multiple Sclerosis and Related Disorders|September 13, 2021
High titers of myelin oligodendrocyte glycoprotein antibody are only observed close to clinical events in pediatricsAllysa Lui, Janet Chong, Eoin Flanagan, et al.
Multiple Sclerosis and Related Disorders|September 13, 2021
Comorbidity and persistence of disease-modifying therapy use in relapsing remitting multiple sclerosisNatalie E Parks, Pantelis Andreou, Ruth Ann Marrie, et al.
Multiple Sclerosis and Related Disorders|June 2, 2020
Are type 1 interferons treatment in Multiple Sclerosis as a potential therapy against COVID-19?Emin Gemcioglu, Mehmet Davutoglu, Ese Ece Ozdemir, et al.
Pageof 505